CBAY 10 Pill - blue & gray capsule/oblong
Generic Name: seladelpar
Pill with imprint CBAY 10 is Blue & Gray, Capsule/Oblong and has been identified as Livdelzi 10 mg. It is supplied by Gilead Sciences, Inc.
Livdelzi is used in the treatment of Primary Biliary Cholangitis and belongs to the drug class miscellaneous metabolic agents. Livdelzi 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CBAY 10
Livdelzi
- Generic Name
- seladelpar
- Imprint
- CBAY 10
- Strength
- 10 mg
- Color
- Blue & Gray (light gray opaque body and dark blue opaque cap)
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous metabolic agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-3301
See also:
Actigall
Actigall is used for gallbladder disease, primary biliary cholangitis
Elafibranor
Elafibranor is used to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic a ...
Ocaliva
Ocaliva may be used to treat primary biliary cholangitis (PBC) in adults without cirrhosis or with ...
Iqirvo
Iqirvo (elafibranor) is used to treat primary biliary cholangitis (PBC) in combination with ...
Urso Forte
Urso Forte is used for gallbladder disease, primary biliary cholangitis
Reltone
Reltone is used for gallbladder disease, primary biliary cholangitis
Obeticholic acid
Obeticholic acid (brand name Ocaliva) may be used to treat primary biliary cholangitis (PBC) in ...
Ursodiol
Ursodiol information from Drugs.com, includes Ursodiol side effects, interactions and indications.
Elafibranor
Elafibranor is used to treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic a ...
More about Livdelzi (seladelpar)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- FDA approval history
- Drug class: miscellaneous metabolic agents
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.